Aim: This experimental study was carried out to biochemically compare the effects of methylprednisolone (MP) alone and in combination with human recombinant erythropoietin (EPO) on malondialdehyde (MDA), superoxide dismutase (SOD) and catalase. Material and Methods: Twenty-four adult male Sprague-Dawley rats were randomly divided into three groups. Spinal cord injury (SCI) was created after laminectomy in all three groups. No treatment was given to the trauma group. In the MP group, 30mg/kg fast (within 15 minutes), and after 45 minutes, intraperitoneal MP was administered in 4 equal doses of 5.4 mg/kg continuously within 23 hours. In the EPO + MP group, 1000IU/kg intraperitoneal EPO was given in addition to the MP given in the same way....
Spinal cord injury (SCI) results in rapid and significant oxidative stress. This study was aimed to ...
This study evaluates the effects of etofenamate on secondary damage following a spinal cord injury ...
EVLIYAOGLU, CETIN AYHAN/0000-0002-1774-3084; GAZYAGCI, SERKAL/0000-0002-0043-6942WOS: 00028158730001...
Introduction: Recent studies have demonstrated that alpha-lipoic acid (ALA) has a strong antioxidant...
Introduction: Recent studies have demonstrated that alpha-lipoic acid (ALA) has a strong antioxidant...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
OBJECTIVE: To evaluate the effects of interleukin-6 (IL-6) and erythropoietin (EPO) in experimental ...
OBJECTIVE: To evaluate the effects of interleukin-6 (IL-6) and erythropoietin (EPO) in experimental ...
WOS: 000305637300003PubMed ID: 22310070Background: Spinal cord injury (SCI) is a leading cause of mo...
PubMed ID: 22310070Background: Spinal cord injury (SCI) is a leading cause of morbidity and mortalit...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
OBJECTIVE: To evaluate the functional and histological effects of ganglioside G(M1) and erythropoiet...
WOS: 000466103300006PubMed ID: 31023039In this study, we aimed to investigate the effectiveness of e...
Erythropoietin (EPO), originally identified for its critical function in regulating production and s...
Spinal cord injury (SCI) results in rapid and significant oxidative stress. This study was aimed to ...
This study evaluates the effects of etofenamate on secondary damage following a spinal cord injury ...
EVLIYAOGLU, CETIN AYHAN/0000-0002-1774-3084; GAZYAGCI, SERKAL/0000-0002-0043-6942WOS: 00028158730001...
Introduction: Recent studies have demonstrated that alpha-lipoic acid (ALA) has a strong antioxidant...
Introduction: Recent studies have demonstrated that alpha-lipoic acid (ALA) has a strong antioxidant...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
OBJECTIVE: To evaluate the effects of interleukin-6 (IL-6) and erythropoietin (EPO) in experimental ...
OBJECTIVE: To evaluate the effects of interleukin-6 (IL-6) and erythropoietin (EPO) in experimental ...
WOS: 000305637300003PubMed ID: 22310070Background: Spinal cord injury (SCI) is a leading cause of mo...
PubMed ID: 22310070Background: Spinal cord injury (SCI) is a leading cause of morbidity and mortalit...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
Inflammation plays a major pathological role in spinal cord injury (SCI). Although antiinflammatory ...
OBJECTIVE: To evaluate the functional and histological effects of ganglioside G(M1) and erythropoiet...
WOS: 000466103300006PubMed ID: 31023039In this study, we aimed to investigate the effectiveness of e...
Erythropoietin (EPO), originally identified for its critical function in regulating production and s...
Spinal cord injury (SCI) results in rapid and significant oxidative stress. This study was aimed to ...
This study evaluates the effects of etofenamate on secondary damage following a spinal cord injury ...
EVLIYAOGLU, CETIN AYHAN/0000-0002-1774-3084; GAZYAGCI, SERKAL/0000-0002-0043-6942WOS: 00028158730001...